secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2024-05-24T23:59:59+00:00
Accession:  0001479681-24-000005
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health receives Nasdaq delisting notice for bid price non-compliance; appeals, hearing July 9
--------------------------------------------------------------------------------

- Nasdaq notified Nutex that it failed to regain the $1.00 minimum bid price by May 20, 2024.
- Company requested an appeal hearing before Nasdaq Hearings Panel, staying delisting; hearing set for July 9, 2024.
- Board approved a reverse stock split (1:2 to 1:16) subject to shareholder vote at June 17, 2024 Annual Meeting.
- If appeal fails and compliance not regained, common stock could be suspended from Nasdaq trading.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000147968124000005/0001479681-24-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000147968124000005/nutx-20240521x8k.htm
  HTML page:      https://secwatch.observer/filing/0001479681-24-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer